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a b s t r a c t
This study is to investigate the clinical and pathologic features of sporadic inclusion body
myositis (sIBM) in China. We retrospectively evaluated the clinical and pathological features
of consecutive patients in our department between January 1986 to May 2012. Total 28 cases
of sIBM (20 males, 8 females, mean age was 56.93  8.79) were obtained by review of all 4099
muscle biopsy reports. The proportion of sIBM was 0.68% (28/4099) in China. Muscle
weakness of quadriceps appeared 100% in 28 cases, while conspicuous atrophy of quadri-
ceps appeared only in ﬁve cases (17.86%). Creatase values of 28 patients with sIBM were
normal or mildly elevated. Muscle biopsies showed that atrophic ﬁbers resembled more
frequent in small angular and irregular shape (82.14%), less common in small round shape
(17.86%). Rimmed vacuoles resembled crack (67.86%) and round (32.14%) shape. Mononu-
clear cell invasion into necrotic muscle ﬁbers (35.71%) was more frequent than non-necrotic
muscle ﬁbers (7.14%). sIBM was still a rare disease in China compared to other countries.
There were some certain speciﬁc pathological characteristics existed in Chinese sIBM
patients.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http://www.elsevier.com/locate/pjnns1. Introduction
Sporadic inclusion body myositis (sIBM), a progressive
inﬂammatory skeletal muscle disease, occurs mainly in over
60-year-old patients [1]. The clinical and pathological
features of sIBM were available in many countries, but did
not reported in China. Since technique of enzyme-histo-
chemistry method in muscle biopsy was not popularly for
myopathy, few sIBM cases were studied and reported in
China [2]. Meanwhile, there was also rare epidemiological* Corresponding author at: Department of Neurology, Chinese PLA Ge
Tel.: +86 10 66939721; fax: +86 10 66939721.
E-mail address: pucq30128@sina.cn (C. Pu).
http://dx.doi.org/10.1016/j.pjnns.2015.06.004
0028-3843/# 2015 Polish Neurological Society. Published by Elsevier Sdata of sIBM in the world. The prevalence rate was reported
differently among different countries and ethnic groups [3].
And the epidemiological data of sIBM in China was not
available yet.
To study the clinical and pathological features of sIBM in
China, we investigated the clinical manifestations, serological
examination, electrophysiology, and muscle pathology in 28
sIBM cases. In addition, we surveyed all suspected myopathy
patients who were subjected to muscle biopsy in our
department. And we calculated an indirect epidemiological
prevalence rate of sIBM in China.neral Hospital, 28 FuXing Road, 100853 Beijing, China.
p. z o.o. All rights reserved.
Table 1 – Clinical symptom of 28 patients with sIBM.
Clinical manifestation Cases Percentage (%)
Onset symptom
Upper limbs weakness 5 17.86
Lower limbs weakness 17 60.71
Four limbs weakness 6 21.43
Clinical symptoms
Facial muscle weakness 2 7.14
Dysphagia 2 7.14
Neck muscle weakness 9 32.14
Proximal upper limb weakness 22 78.57
Distal upper limb weakness 23 82.14
Proximal lower limb weakness 28 100
Distal lower limb weakness 20 71.43
Quadriceps atrophy 5 17.86
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 2 4 5 – 2 5 02462. Patients and methods
2.1. Patients
From January 1986 to May 2012, a total of 4099 patients with
suspected myopathy around China were subjected to muscle
biopsies in the neuropathology laboratory of our hospital. 28
patients were diagnosed as sIBM. All their medical records,
electromyography (EMG) reports and muscle histopathology
were collected. The muscle biopsies sites in this study were
quadriceps and/or biceps. All 28 patients did not have dysphagia.
The diagnose depended on 2011 European Neuromuscular
Centre diagnostic criteria for inclusion body myositis [4].
2.2. Data collection
Study protocol data included: (1) detailed general history:
gender, age at onset, initial symptom or sign, clinical course,
family history; (2) muscle power: manual muscle testing
(extremities, facial muscles, oculorotatory muscles), pharyn-
geal portion muscles, distribution and degree of muscle
weakness and atrophy, progression pattern; (3) laboratory
data: serum creatine kinase, nerve conduction velocity,
muscle biopsy and other examination.
2.3. Histopathologic study
Muscle samples were frozen in liquid nitrogen immediately
after removal and stored at 80 8C. Transverse serial frozen
muscle sections were stained with hematoxylin and eosin
(H&E), periodic acid-Schiff (PAS), oil red O (ORO), Gomori
trichrome stain, nicotinamide adenine dinucleotide dehydro-
genase (NADH), nonspeciﬁc esterase (NSE) and adenosine
triphosphatase (ATPase) staining after incubation in pH 4.3, 4.5
and 10.6. Morphometric evaluation of muscle specimens was
performed by light microscopy. Ultrathin sections were
prepared in epon-embedded material, stained with osmic
acid and examined by an electron microscope.
2.4. Statistical analysis
Dichotomous variables were analyzed by chi-square test;
continuous variables were presented as mean  SD and
analyzed by Mann–Whitney U-test. All statistical tests were
two-tailed. P < 0.05 was considered as statistically signiﬁcant.
In this study, all statistical analysis was performed by SPSS13.0
statistical software.
3. Results
3.1. Prevalence and onset age
We analyzed 28 patients with sIBM in our department from
January 1986 to May 2012. The results showed that the
proportion of sIBM was 0.68% (28/4099) in this group.
Among all 28 patients with sIBM, there were 20 male
patients (71.43%) and 8 female patients (28.57%). The onset age
ranged from 38 to 71 years (51.5  7.3 years). The diagnosis ageranged from 41 to 78 years (56.93  8.79 years). In detail, three
patients were 40–49 years old (10.71%), 16 patients were 50–59
years old (57.14%), 6 patients were 60–69 years old (21.43%), and
3 patients were older than 70 (10.71%). And the time course
from onset to diagnosis ranged from 1.5 to 14 years (5.54  3.15
years), which was 5.15  3.56 years for men and 6.5  1.51
years for women, respectively.
3.2. Clinical features
The clinical course of 28 patients with sIBM was chronic and
progressive. As for the onset symptom of total 28 patients with
sIBM, 17 cases presented both lower limbs weakness (60.71%),
5 cases for both upper limbs (17.86%) and 6 cases for four limbs
weakness (21.43%). More clinical details were listed in Table 1.
3.3. Laboratory examination
Serum creatase of 28 patients with sIBM were normal or mildly
elevated. The mean serum CK value of 28 patients with sIBM
was 397.38  295.06 (79–1384) u/L. The mean serum LDH value
of 28 patients with sIBM was 218.21  64.32 (120–374) u/L. The
mean serum ALT and AST value was 30.21  18.41 (12–97) u/L
and 27.67  13.85 (11–56) u/L, respectively.
The sIBM patients' creatase values between different
disease duration groups were listed as supplemental data.
CK values of patients with sIBM for less than 5 years duration
were signiﬁcantly higher than that of more than 5 years
duration (544.82  376.34 vs. 272.62  109.78) u/L (P < 0.05).
Also, ALT values were higher in patients with <5 years
duration than that in patients with ≥5 years duration
(38.82  21.79 vs. 22.92  11.32) u/L (P < 0.05).
EMG reports showed that there were 21 cases with
myogenic lesion, while seven cases with both myogenic lesion
and neurogenic lesion.
3.4. Myopathological features
Pathological features of patients with sIBM were summarized
in Table 2. Atrophic ﬁbers presented small angularity or
irregularity (82.14%, 23/28) (Fig. 1A) and small round shape
(17.86%, 5/28) (Fig. 1B). Rimmed vacuoles resembled crack
(Fig. 2A) (67.86%, 19/28) or round (Fig. 1C) (32.14%, 9/28).
Fig. 1 – Morphous of rimmed vacuoles and inclusion bodies showed as below. (A) Many atrophic fibers showed as small-
angular (arrow), in which there were some rimmed vacuoles (hematoxylin & eosin, original magnification T100). (B) In this
cross-section of muscle, many atrophic fibers showed as small-small-rounded, in which there were some rimmed vacuoles,
with some internal nuclei within fiber, disintegration and hypertrophy of fibers (hematoxylin & eosin, original magnification
T100). (C) This was a magnification of (A). Many fine particle-like inclusion bodies located in round rimmed vacuoles in fiber
(hematoxylin & eosin, original magnification T200). (D) Many coarse particle-like inclusion bodies were seen in round
rimmed vacuole of fiber, while other fine particle-like inclusion bodies were seen in crack rimmed vacuoles (hematoxylin &
eosin, original magnification T400).
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(Figs. 1C and 2D) (78.57%, 22/28) and coarse granules (21.43%,
6/28) (Fig. 1D). Only two cases (7.14%) presented mononuclear
cell invasion in non-necrotic muscle ﬁbers (Fig. 2B), while 10
cases presented mononuclear cell invasion in necrotic muscle
ﬁbers (35.71%) (Fig. 2A). Inﬂammatory cell inﬁltration was
observed (Fig. 2C) in 15 cases (53.57%), but not observed in the
other 13 cases (46.43%). Moreover, inﬁltration of inﬂammatory
cells in the walls of perimysial venules and arterioles (Fig. 2D)
was observed in nine cases (32.14%). For Gomori trichrome
staining, RRF (Fig. 3A) was observed in three patients' muscle
samples (10.71%) while red staining inclusion bodies (Fig. 3B)
were showed in all samples. Excess lipid droplets in three
cases presented positive for ORO staining (10.71%). ATPase
staining showed an equal distribution of muscle ﬁber types in
24 cases (85.71%). However, type I ﬁber was observed
dominantly in only three cases (10.71%), and type II ﬁber
presented dominantly in only one case (3.57%).
4. Discussion
Sporadic inclusion body myositis is a distinct progressive
inﬂammatory skeletal muscle disease. Its cause and effectivetreatment still remains unknown [5]. It usually occurs in over
50-year-old patients. In 1967, Chou [6] ﬁrst described the
speciﬁc pathological manifestation of inclusion body and
rimmed vacuoles. In 1971, Yunis and Smamha [7] ﬁrst
introduced the concept of inclusion body myositis. It was
veriﬁed later by Carpenter et al. [8] and reported clinical feature
in progressive course and ﬁnger ﬂexor, wrist ﬂexor and knee
ﬂexors.
The epidemiological data of sIBM was reported distinc-
tively among different countries and ethnic groups. The
prevalence rate was reported to be 4.9 per million in the
Netherlands [9], 9.3 per million in Western Australia (WA)
[10] and 10.7 per million in Connecticut, USA [11]. Because
muscle biopsy was not popularly in suspected myopathy
patients, there were only few case reports of sIBM published,
and no epidemiological data was reported in China. In our
study, we investigated total 4099 patients with possible
neuromuscular disorders all over the country from January
1986 to May 2012. All patients were examined by muscle
biopsy. And among these 4099 cases, total 28 cases of sIBM
patients were analyzed and the proportion of sIBM cases was
calculated to be 0.68%. Since the patients were from the
whole country, it represented indirect epidemiological data
of sIBM in China.
Fig. 2 – Infiltration of inflammatory cells showed as below. (A) Many fine particle-like inclusion bodies adhered to wall of crack
rimmed vacuole in fiber. Mononuclear cell invasion of necrotic muscle fibers could be seen (hematoxylin & eosin, original
magnification T200). (B) Mononuclear cell invasion (arrow) of non-necrotic muscle fibers (hematoxylin & eosin, original
magnification T400). (C) Many inflammatory cells infiltrated gaps between fibers (hematoxylin & eosin, original
magnification T200). (D) Infiltration of inflammatory cells in the walls of perimysial vessel (hematoxylin & eosin, original
magnification T 200).
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quadriceps and less common in the ﬁnger ﬂexors and
pharyngeal muscles. And quadriceps weakness tended to
occur more frequently in men. Our study partly afﬁrmed these
results in Chinese patients. Among 28 sIBM patients, 20 cases
were male and 8 cases for female. The male-to-female ratio
was 2.5:1. Onset symptom showed most frequent in theFig. 3 – Gomori trichrome staining of muscle histopathology in pa
(original magnification T200) and (B) inclusion bodies of some r
magnification T200). (For interpretation of the references to colo
version of the article.)quadriceps and less common in the forearm muscles, but no
case in the pharyngeal muscles.
Quadriceps occurred most frequently as others reported.
But in this study, although lower limbs weakness proportion
was 100% in 28 sIBM patients, only ﬁve cases showed obvious
quadriceps atrophy (17.86%), which was slightly different from
other countries.tients with sIBM demonstrating (A) RRF was showed (arrow)
immed vacuoles in fibers were stained as red (original
r in this figure legend, the reader is referred to the web
Table 2 – Pathological features of 28 sIBM patients.
Cases Percentage
(%)
Morphous of atrophic muscle ﬁber
Small angular 9 32.14
Small round 5 17.86
Irregular 14 50.00
Internal nuclei within ﬁber 12 42.86
Muscle ﬁber hypertrophy and split 18 64.29
Morphous of rimmed vacuoles
Crack 19 67.86
Round 9 32.14
Rimmed vacuoles protrude 2 7.14
Morphous of inclusion body
Fine particles 22 78.57
Coarse particles 6 21.43
Mononuclear cell invasion of
non-necrotic muscle ﬁber
2 7.14
Mononuclear cell invasion of
necrotic muscle ﬁber
10 35.71
Inﬂammatory cell inﬁltration 15 53.57
No inﬂammatory cell inﬁltration 13 46.43
Peri-vascular inﬂammatory
inﬁltration
9 32.14
No peri-vascular inﬂammatory
inﬁltration
19 67.86
RRF 3 10.71
Red staining inclusion body in
Gomori trichrome stain
28 100
Excess lipid droplets on ORO staining 3 10.71
No excess lipid droplets on ORO staining 25 89.29
Equal distribution of muscle ﬁber type 24 85.71
Type I ﬁber dominantly 3 10.71
Type II ﬁber dominantly 1 3.57
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tion of symptoms, neck and bulbar muscles involvements are
gradually observed, which generally indicates that it signiﬁ-
cantly deteriorated. Without control, it will ﬁnally lead to
respiratory difﬁculties and even death. Therefore, the proba-
bility estimation of the muscles involvements mentioned
above is meaningful to diagnose. Lynn et al. [13] reported that
bulbar muscle was more probably to be involved in sIBMs than
in other inﬂammatory myopathies. Felice and his colleagues
[11] reported that 38–84% sIBM patients suffered from bulbar
muscle. Moreover, bulbar muscle involvement was more
frequent in male patients in a study on 26 cases of sIBM
patients with bulbar muscular disorders [14]. Our study
suggested that only two of the total 28 sIBM cases (7.14%)
involved bulbar muscular, which was different from the
results of the former studies.
Serum creatase values were normal or slightly increased in
these sIBM patients. CK and ALT values were higher in patients
with <5 years duration than that in patients with ≥5 years
duration, indicating that creatase increased signiﬁcantly in
the early cause of sIBM but tended to decrease with the
development of disease. The possible reason was that
the muscle involvements deteriorated and further led to the
muscular atrophy and the reduction of creatase.
The pathological features of sIBM are commonly described
as follows: myoﬁber necrosis and regeneration; endomysial
mononuclear cell inﬁltration; invasion of non-necrotic ﬁbers
by mononuclear cells; vacuolated muscle ﬁbers (rimmedvacuoles); ubiquitin-positive inclusions and amyloid deposits
in muscle ﬁbers; nuclear and/or cytoplasmic 16–20 nm
ﬁlamentous inclusions under electron microscopy [15]. By
contrast, the Chinese sIBM patients in our study followed most
of the regular pathological features. A speciﬁc pathological
feature was that mononuclear cell inﬁltrated more frequent in
necrotic muscle ﬁbers than in non-necrotic muscle ﬁbers. This
might be a special characteristic of Chinese sIBM patients.
Also, we found that rimmed vacuoles resembled crack or
round and inclusion body mostly looked like ﬁne sand-like
granules.
5. Conclusions
In conclusion, the proportion of sIBM in all neuromuscular
disorders was 0.68% in China. The onset symptom of sIBM in
this study was mainly weakness in both lower limbs. Clinical
manifestation mostly showed proximal lower limbs and distal
upper limbs weakness. However, only 17.86% cases were
quadriceps atrophy. Creatase value was normal or mildly
elevated, which was mostly notable in early stage of disease
and not signiﬁcant in later stage. The pathological features of
sIBM followed as below: The atrophic muscle ﬁbers were
mostly presented small angle or irregularity. The rimmed
vacuoles mostly resembled crack and the inclusion body
appeared ﬁne granules as sand-like particles. There were rare
mononuclear inﬁltrations in non-necrotic muscle ﬁber, while
more in necrotic muscle ﬁbers. Half of the cases showed
inﬂammatory cell inﬁltration, and one third of the cases
showed peri-vascular inﬁltration in inﬂammatory cells. The
study provided the evidence for the speciﬁc clinical and
pathological characteristics of sIBM in China and a foundation
for the diagnosis and further research.
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